Grey Zone Lymphomas: Lymphomas with Intermediate Features

The current classification of lymphoid neoplasms is based on clinical information, morphology, immunophenotype, and molecular genetic characteristics. Despite technical and scientific progress, some aggressive B-cell lymphomas with features overlapping between two different types of lymphomas remain...

Full description

Bibliographic Details
Main Authors: Sylvia Hoeller, Christiane Copie-Bergman
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2012/460801
id doaj-c0e2c0ec82c84f649838278223814579
record_format Article
spelling doaj-c0e2c0ec82c84f6498382782238145792021-07-02T09:39:57ZengHindawi LimitedAdvances in Hematology1687-91041687-91122012-01-01201210.1155/2012/460801460801Grey Zone Lymphomas: Lymphomas with Intermediate FeaturesSylvia Hoeller0Christiane Copie-Bergman1Institute of Pathology, University Hospital Basel, 4031 Basel, SwitzerlandAP-HP, Groupe Henri Mondor-Albert Chenevier, Département de Pathologie, Hôpital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, FranceThe current classification of lymphoid neoplasms is based on clinical information, morphology, immunophenotype, and molecular genetic characteristics. Despite technical and scientific progress, some aggressive B-cell lymphomas with features overlapping between two different types of lymphomas remain difficult to classify. The updated 2008 World Health Organization (WHO) classification of Tumours of the Hematopoietic and Lymphoid Tissues has addressed this problem by creation of two new provisional categories of B-cell lymphomas, unclassifiable; one with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma and the second with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. We review here the diagnostic criteria of these two provisional entities and discuss new scientific findings in light of the 2008 WHO classification.http://dx.doi.org/10.1155/2012/460801
collection DOAJ
language English
format Article
sources DOAJ
author Sylvia Hoeller
Christiane Copie-Bergman
spellingShingle Sylvia Hoeller
Christiane Copie-Bergman
Grey Zone Lymphomas: Lymphomas with Intermediate Features
Advances in Hematology
author_facet Sylvia Hoeller
Christiane Copie-Bergman
author_sort Sylvia Hoeller
title Grey Zone Lymphomas: Lymphomas with Intermediate Features
title_short Grey Zone Lymphomas: Lymphomas with Intermediate Features
title_full Grey Zone Lymphomas: Lymphomas with Intermediate Features
title_fullStr Grey Zone Lymphomas: Lymphomas with Intermediate Features
title_full_unstemmed Grey Zone Lymphomas: Lymphomas with Intermediate Features
title_sort grey zone lymphomas: lymphomas with intermediate features
publisher Hindawi Limited
series Advances in Hematology
issn 1687-9104
1687-9112
publishDate 2012-01-01
description The current classification of lymphoid neoplasms is based on clinical information, morphology, immunophenotype, and molecular genetic characteristics. Despite technical and scientific progress, some aggressive B-cell lymphomas with features overlapping between two different types of lymphomas remain difficult to classify. The updated 2008 World Health Organization (WHO) classification of Tumours of the Hematopoietic and Lymphoid Tissues has addressed this problem by creation of two new provisional categories of B-cell lymphomas, unclassifiable; one with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma and the second with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. We review here the diagnostic criteria of these two provisional entities and discuss new scientific findings in light of the 2008 WHO classification.
url http://dx.doi.org/10.1155/2012/460801
work_keys_str_mv AT sylviahoeller greyzonelymphomaslymphomaswithintermediatefeatures
AT christianecopiebergman greyzonelymphomaslymphomaswithintermediatefeatures
_version_ 1721333009706123264